Bharat Coking Coal IPO Allotment Status: Why BCCL IPO's Listing Postponed To January 19 On BSE, NSE? GMP Here

By Admin

15 Jan, 2026

The much-awaited initial public offering of Bharat Coking Coal Limited (BCCL) has entered a crucial phase with the announcement of its allotment status. Backed by Coal India, this PSU IPO has generated massive interest across investor categories. However, investors were taken by surprise after the company announced a delay in its stock market listing, shifting the date from January 16 to January 19, 2026. Here is a detailed look at the allotment process, listing postponement, GMP trends, and listing expectations.

Bharat Coking Coal IPO Allotment Status: How to Check

Investors who applied for the BCCL IPO can check their allotment status through three official platforms:

• Kfin Technologies
  https://ipostatus.kfintech.com/

• BSE
  https://www.bseindia.com/investors/appli_check.aspx

• NSE
  https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

To check the status, applicants need any one of the following details:

• Application number

• PAN card number

• Demat account number

The process is simple and allows investors to quickly confirm whether shares have been allotted.

Why Bharat Coking Coal IPO Listing Was Postponed

The BCCL IPO shares were initially scheduled to list on January 16, 2026, on BSE and NSE. However, the listing has now been deferred to January 19, 2026.

According to Sebi-registered analyst Vibhor Varshney, the postponement is due to a stock market and banking holiday in Maharashtra on account of the BMC elections. The delay is purely logistical and not linked to the company’s fundamentals or subscription response, meaning investors need not worry about the change in listing date.

Bharat Coking Coal IPO GMP Today

The latest grey market premium (GMP) for the Bharat Coking Coal IPO stands at Rs 13, last updated on January 15, 2026, at 07:00 AM. With an issue price of Rs 23, the estimated listing price is around Rs 36 per share.

This implies an expected gain of approximately 56.52 percent per share, as per Investor Grain. The sustained double-digit GMP suggests strong listing expectations despite the brief delay.

BCCL IPO Creates History in Indian Primary Markets

BCCL launched its Rs 1,071.11 crore IPO on January 9, and the subscription window closed on January 13. By the final day, the issue was oversubscribed a staggering 146.87 times, making it the second most subscribed PSU IPO in India.

The IPO also set a new benchmark by attracting nearly 90 lakh applications, the highest ever for any PSU IPO in the Indian primary market. This overwhelming response highlights extraordinary investor confidence in the company and the broader Coal India ecosystem.

Bharat Coking Coal IPO Listing Prediction

Market experts remain optimistic about BCCL’s debut on the stock exchanges. The issue price has been fixed at Rs 23, and analysts expect a strong listing on both BSE and NSE.

According to Gaurav Garg, Research Analyst at Lemonn Markets Desk, the strong demand reflects investor confidence in BCCL’s monopolistic position in India’s coking coal segment and its long-term demand visibility.

He further noted that the anchor book was fully subscribed at 1x, with 11.88 crore shares allotted, raising Rs 273.13 crore. This provided early institutional validation to the IPO. Exceptional oversubscription in the NII category signals strong valuation comfort and expectations of listing gains.

Garg also highlighted that healthy participation from retail and shareholder categories shows broad-based investor trust. While QIB demand remained relatively measured, the overall subscription trend points to favourable secondary market sentiment. The scarcity value of a pure-play coking coal producer and steady demand from the steel sector continue to support a positive outlook.

Should Investors Be Concerned About the Listing Delay?

The short postponement of the BCCL IPO listing is due to a regional holiday and not any regulatory or business-related issue. Given the historic oversubscription, strong GMP, and positive analyst commentary, the delay is unlikely to impact listing performance. For most investors, the fundamentals and demand dynamics remain firmly intact as BCCL prepares to debut on January 19, 2026.